Bladder cancer has been a problem for many people in the United States
alone and a prescription drug called Actos is most likely to blame. Actos and
other pioglitazone medications are created by Takeda Pharmaceuticals. The
victims each filed their own Actos
lawsuit against the establishment to receive compensation for the
damages caused by taking the drug. The lawsuits state that Takeda
Pharmaceuticals failed to warn patients about the risk of bladder cancer when
they take the medication for several months. Because of this, millions of
patients have been at risk of developing bladder cancer or heart failure while
receiving treatment for Type 2 Diabetes.
As of September 2011, 54 lawsuits have been filed against Takeda
Pharmaceuticals relating to Actos bladder cancer alone. In the present day,
hundreds of lawsuits are filed in district courts around the United States.
This includes claims in New York, Ohio, California, and Florida. Some people
who have filed an Actos lawsuit
are on behalf of family members who have died from bladder cancer and other
health complications because of taking Actos. Plaintiffs allege that the drug
was not researched properly and that they were not warned about the risks of
acquiring bladder cancer and other health problems caused by the drug.
Sources around the web say that the number of lawsuits the
manufacturers will face can be as high as 10,000. Most of these lawsuits allege
that Takeda Pharmaceuticals knew of the side effects but kept it from the
public’s knowledge. Many complaints seek to be paid millions of dollars due to
the damages, lost income, medical expenses, and loss of consortium because of
taking Actos for years.
A lawsuit filed by a woman who is 54 years old states that she took
Actos for more than 10 years and had symptoms of bladder cancer. She was later
diagnosed with the ailment. Her medical bills are mounting and she is concerned
about keeping her job while going through chemotherapy and multiple surgeries.
Another lawsuit by a warehouse worker in his late 50’s asserted that he took
Actos for about five years before his doctor informed him that he had bladder
cancer. He is currently facing several surgeries as well. While treating their
Type 2 Diabetes, many have been placed at risk of developing serious health
conditions. The burden of the sickness is long-term, thus costly, which is why
victims seek to be recompensed by the makers of Actos. Since Actos is being
distributed by another company in the United States, both Takeda and Eli Lilly
& Co. are the subjects to the litigations.
No comments:
Post a Comment